Skip to main content
. 2021 Dec 23;19:81. doi: 10.1186/s12962-021-00334-z

Table 4.

Cost-effectiveness results in three patient subgroups

Subgroup BNP Standard clinical assessment Incremental cost per QALY gained (BNP vs. standard clinical Assessment)
Cost (USD) QALYs Cost (USD) QALYs
45–55 years $1100 2.07 $1280 1.24 Dominant
55–65 years $1540 1.65 $1400 1.35 USD 466
65–75 years $2700 1.24 $2050 1.02 USD 2954

BNP, B-type natriuretic peptide; QALYs, quality-adjusted life-years; USD, United States Dollars